Post hoc analysis of a phase 2 trial in 45 adults aged 60-74 or 85+: one dose of a GI.1/GII.4c norovirus vaccine raised neutralising antibody titres against all GII.4 variants at day 57; titres fell by day 393, staying highest against ancestral strains.
Secondary analysisn = 45
Lindesmith et al. Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trial